QSI
Quantum-Si incorporated
$0.88
-0.08
(-8.28%)
Mkt Cap
174.62M
Volume
2,852,567
52W Range
0.691-3.1
Sector
Healthcare
Beta
3.20
EPS (TTM)
-0.51
P/E Ratio
-2.16
Revenue (TTM)
1.85M
Rev Growth (5Y)
N/A
EPS Growth (5Y)
N/A
Company Description
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.44M | 3.06M | 1.08M | 0 | 0 | 0 | 0 |
| Net Income | (101.34M) | (101.01M) | (95.96M) | (132.44M) | (94.99M) | (36.61M) | (35.80M) |
| EPS | -0.51 | -0.71 | -0.68 | -0.95 | -1.19 | -6.81 | -0.26 |
| Free Cash Flow | (97.23M) | (92.38M) | (99.31M) | (101.30M) | (72.58M) | (33.03M) | (31.95M) |
| FCF / Share | -0.49 | -0.65 | -0.70 | -0.73 | -0.91 | -6.14 | -0.23 |
| Operating CF | (94.72M) | (87.80M) | (94.04M) | (90.56M) | (66.81M) | (32.57M) | (30.71M) |
| Total Assets | 245.61M | 247.87M | 298.25M | 391.49M | 503.23M | 40.59M | 37.41M |
| Total Debt | 4.17M | 12.95M | 15.30M | 17.45M | 8.08M | 1.75M | 0 |
| Cash & Equiv | 21.64M | 49.24M | 133.86M | 84.32M | 35.78M | 36.91M | 32.93M |
| Book Value | 220.23M | 215.42M | 271.62M | 358.71M | 477.03M | 36.09M | 35.46M |
| Return on Equity | -0.46 | -0.47 | -0.35 | -0.37 | -0.20 | -1.01 | -1.01 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 258,000 | 451,000 | 552,000 | 591,000 | 842,000 | 1.19M | 787,000 | 622,000 | 457,000 | 400,000 | 223,000 | 205,000 |
| Net Income | (21.67M) | (17.61M) | (35.70M) | (28.84M) | (19.19M) | (33.12M) | (25.31M) | (23.10M) | (19.47M) | (22.05M) | (24.73M) | (25.57M) |
| EPS | -0.10 | -0.08 | -0.17 | -0.16 | -0.11 | -0.23 | -0.18 | -0.16 | -0.14 | -0.16 | -0.17 | -0.18 |
| Free Cash Flow | (25.92M) | (16.33M) | (32.92M) | (20.52M) | (27.46M) | (24.32M) | (24.13M) | (19.68M) | (24.31M) | (20.60M) | (22.82M) | (23.73M) |
| FCF / Share | -0.12 | -0.08 | -0.16 | -0.11 | -0.15 | -0.17 | -0.17 | -0.14 | -0.17 | -0.15 | -0.16 | -0.17 |
| Operating CF | (25.64M) | (16.35M) | (32.02M) | (20.20M) | (26.15M) | (22.88M) | (23.15M) | (18.55M) | (23.21M) | (20.97M) | (21.44M) | (22.93M) |
| Total Assets | 213.35M | 245.61M | 260.13M | 254.41M | 271.22M | 247.87M | 236.45M | 256.75M | 275.58M | 298.25M | 318.10M | 341.17M |
| Total Debt | 3.71M | 4.17M | 4.61M | 11.14M | 12.05M | 12.95M | 13.82M | 13.65M | 14.48M | 15.30M | 15.45M | 16.21M |
| Cash & Equiv | 36.20M | 21.64M | 30.91M | 22.19M | 37.29M | 49.24M | 42.27M | 59.55M | 53.16M | 133.86M | 93.82M | 87.93M |
| Book Value | 200.74M | 220.23M | 235.16M | 220.98M | 246.92M | 215.42M | 210.52M | 233.26M | 253.77M | 271.62M | 292.06M | 315.30M |
| Return on Equity | -0.11 | -0.08 | -0.15 | -0.13 | -0.08 | -0.15 | -0.12 | -0.10 | -0.08 | -0.08 | -0.08 | -0.08 |
QSI News
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
euNetworks launches new quantum-safe private connectivity service powered by Adtran's encrypted optical transport technology
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Q1 Earnings Call Highlights
Quantum-Si Incorporated (QSI) Reports Q1 Loss, Misses Revenue Estimates